TrialJournal of neuro-oncology2025

Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapy.

Debra Nana Yeboa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.